Hyzaar Forte

Losartan potassium, the active ingredient in Hyzaar Forte, is an angiotensin II receptor blocker presented as a combined tablet for oral use. It is used to treat hypertension, often in combination with a thiazide diuretic, and is prescribed for adult patients who require blood pressure control.

GNH USA supplies Hyzaar Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export, ensuring product integrity across global supply chains.

Hyzaar Forte, an ARB/thiazide diuretic combination, is indicated for conditions related to high blood pressure.

- Hypertension: lowers systolic and diastolic pressure in patients with essential hypertension. - Heart failure: assists in reducing fluid overload and improves cardiac output when used alongside standard therapy. - Diabetic nephropathy: helps slow the progression of kidney damage associated with diabetes by controlling blood pressure.

Hyzaar Forte may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Dizziness - Headache - Increased urination - Electrolyte disturbances (e.g., low potassium)

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Acute kidney injury - Hyperkalemia

When prescribing Hyzaar Forte, clinicians should observe several precautionary measures to ensure patient safety.

- Monitor blood pressure: check regularly after initiation and dose adjustments. - Assess renal function: evaluate serum creatinine and eGFR before and during therapy. - Check electrolytes: especially potassium and sodium levels. - Avoid use in pregnancy: drug is classified as Category D and may harm the fetus. - Use caution in elderly: increased sensitivity to blood‑pressure changes. - Store at room temperature: keep tablets in the original container, protect from moisture and heat.

Hyzaar Forte can interact with several medicines; awareness of these interactions helps maintain therapeutic effectiveness.

Major Interactions (Avoid): - Aliskiren: concurrent use may increase risk of renal impairment and hyperkalemia. - Potassium supplements or potassium‑sparing diuretics: can cause dangerous hyperkalemia. - NSAIDs (e.g., ibuprofen, naproxen): may reduce antihypertensive effect and impair kidney function.

Moderate Interactions (Monitor Closely): - ACE inhibitors or other ARBs: additive blood‑pressure lowering may cause hypotension. - Lithium: thiazide component can raise lithium levels, risking toxicity. - Other antihypertensives (beta‑blockers, calcium channel blockers): may require dose adjustments.